11th May 2015 17:31
TR-1: NOTIFCATION OF MAJOR INTEREST IN SHARES
| ||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | Silence Therapeutics plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | ||||
Other (please specify): | Dilution due to additional placing of shares | X | ||
3. Full name of person(s) subject to thenotification obligation: | ROBERT KEITH | |||
4. Full name of shareholder(s) (if different from 3.): | ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 8 May 2015 | |||
6. Date on which issuer notified: | 11 May 2015 | |||
7. Threshold(s) that is/are crossed orreached: | 23%, 22%, 21%, 20%, 19% | |||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
GB00B9GTXM62 | 10,880,787 | 10,880,787 | 11,297,453 | 11,297,453 | 16.18 | |||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted | % of votingrights | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
| |||||||||||
Spreadbet | n/a | n/a | n/a |
1,299,521 | Nominal | Delta | ||||||||||
1.86 | ||||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
12,596,974 | 18.04% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will ceaseto hold: | ||
12. Date on which proxy holder will cease to holdvoting rights: | ||
13. Additional information: | ||
14. Contact name: | ROBERT KEITH | |
15. Contact telephone number: | ||
Related Shares:
SLN.L